DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
FRA:DMP - Deutsche Boerse Ag - DE000A2GS5D8 - Common Stock - Currency: EUR
Overall DMP gets a fundamental rating of 5 out of 10. We evaluated DMP against 52 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of DMP while its profitability can be described as average. DMP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
DMP had positive earnings in the past year.
In the past year DMP had a positive cash flow from operations.
DMP had positive earnings in each of the past 5 years.
DMP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DMP has a Return On Assets (4.90%) which is comparable to the rest of the industry.
DMP's Return On Equity of 16.22% is fine compared to the rest of the industry. DMP outperforms 65.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.14%, DMP is in line with its industry, outperforming 46.15% of the companies in the same industry.
DMP had an Average Return On Invested Capital over the past 3 years of 9.78%. This is significantly below the industry average of 15.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROIC | 7.14% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP's Profit Margin of 8.74% is in line compared to the rest of the industry. DMP outperforms 42.31% of its industry peers.
DMP's Profit Margin has declined in the last couple of years.
DMP's Operating Margin of 17.82% is in line compared to the rest of the industry. DMP outperforms 50.00% of its industry peers.
DMP's Operating Margin has improved in the last couple of years.
The Gross Margin of DMP (64.76%) is worse than 61.54% of its industry peers.
In the last couple of years the Gross Margin of DMP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
DMP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DMP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.14 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.14, DMP is in line with its industry, outperforming 44.23% of the companies in the same industry.
DMP has a debt to FCF ratio of 7.58. This is a slightly negative value and a sign of low solvency as DMP would need 7.58 years to pay back of all of its debts.
DMP has a Debt to FCF ratio of 7.58. This is comparable to the rest of the industry: DMP outperforms 40.38% of its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that DMP has dependencies on debt financing.
DMP's Debt to Equity ratio of 1.43 is on the low side compared to the rest of the industry. DMP is outperformed by 73.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Altman-Z | 2.14 |
ROIC/WACC1.19
WACC6.01%
2.3 Liquidity
DMP has a Current Ratio of 2.05. This indicates that DMP is financially healthy and has no problem in meeting its short term obligations.
DMP has a better Current ratio (2.05) than 76.92% of its industry peers.
DMP has a Quick Ratio of 2.05. This is a bad value and indicates that DMP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DMP (0.91) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 83.06% over the past year.
The Earnings Per Share has been growing by 8.07% on average over the past years. This is quite good.
DMP shows a small growth in Revenue. In the last year, the Revenue has grown by 6.24%.
The Revenue has been growing by 11.00% on average over the past years. This is quite good.
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
3.2 Future
The Earnings Per Share is expected to grow by 13.11% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.63% on average over the next years.
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 17.66, DMP is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as DMP.
Compared to an average S&P500 Price/Earnings ratio of 27.53, DMP is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.03, which indicates a correct valuation of DMP.
Based on the Price/Forward Earnings ratio, DMP is valued a bit cheaper than the industry average as 63.46% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DMP to the average of the S&P500 Index (36.71), we can say DMP is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.66 | ||
| Fwd PE | 13.03 |
4.2 Price Multiples
DMP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DMP is cheaper than 71.15% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DMP is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.9 | ||
| EV/EBITDA | 9.08 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DMP's earnings are expected to grow with 12.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.21
PEG (5Y)2.19
EPS Next 2Y12.79%
EPS Next 3Y12.29%
5. Dividend
5.1 Amount
DMP has a Yearly Dividend Yield of 2.60%.
DMP's Dividend Yield is a higher than the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.34, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DMP pays out 45.74% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45.74%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
FRA:DMP (7/22/2025, 7:00:00 PM)
33.9
-0.15 (-0.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners14.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.83B
Analysts80
Price Target46.31 (36.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP45.74%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.37%
PT rev (3m)-6.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.66 | ||
| Fwd PE | 13.03 | ||
| P/S | 1.54 | ||
| P/FCF | 13.9 | ||
| P/OCF | 10.58 | ||
| P/B | 2.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.08 |
EPS(TTM)1.92
EY5.66%
EPS(NY)2.6
Fwd EY7.67%
FCF(TTM)2.44
FCFY7.19%
OCF(TTM)3.2
OCFY9.45%
SpS22
BVpS11.86
TBVpS-8.21
PEG (NY)1.21
PEG (5Y)2.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.9% | ||
| ROE | 16.22% | ||
| ROCE | 11.69% | ||
| ROIC | 7.14% | ||
| ROICexc | 7.64% | ||
| ROICexgc | 21.24% | ||
| OM | 17.82% | ||
| PM (TTM) | 8.74% | ||
| GM | 64.76% | ||
| FCFM | 11.08% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexcg growth 3Y-9.69%
ROICexcg growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | 7.58 | ||
| Debt/EBITDA | 3.07 | ||
| Cap/Depr | 47.38% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 3.84 | ||
| Cash Conversion | 57.88% | ||
| Profit Quality | 126.76% | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.14 |
F-Score7
WACC6.01%
ROIC/WACC1.19
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)83.06%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%-23.48%
EPS Next Y14.57%
EPS Next 2Y12.79%
EPS Next 3Y12.29%
EPS Next 5Y13.11%
Revenue 1Y (TTM)6.24%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%1.24%
Revenue Next Year0.58%
Revenue Next 2Y2.35%
Revenue Next 3Y2.31%
Revenue Next 5Y2.63%
EBIT growth 1Y28.45%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.91%
EBIT Next 3Y19.98%
EBIT Next 5Y6.79%
FCF growth 1Y-54.33%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-46.56%
OCF growth 3Y-7%
OCF growth 5Y14.89%